BioWorld

Sichuan Kelun Pharmaceutical synthesizes CYP51 inhibitors

Sichuan Kelun Pharmaceutical Co. Ltd. has discovered new lanosterol 14α-demethylase (CYP51) inhibitors reported to be useful for the treatment of Candidal infection and aspergillosis.
Goethe

ΒΡΑΒΕΙΑ LUX – KINO Athens 2026

Η 4η έκδοση του KINO Athens International Independent Film Festival ανακοινώνει για άλλη μία χρονιά με ιδιαίτερη χαρά τις προβολές των υποψήφιων ταινιών για το ...
C&EN

Exploring Long Arm Amide-Linked Side Chains in the Design of Antifungal Azole Inhibitors of Sterol 14α-Demethylase (CYP51)

School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff CF10 3NB, U.K.
BioWorld

Convelo and Genentech describe new CYP51 inhibitors

Convelo Therapeutics Inc. and Genentech Inc. have identified lanosterol 14α-demethylase (CYP51A1; CYP51) inhibitors reported to be useful for the treatment of multiple sclerosis, encephalomyelitis, ...
C&EN

Lanosterol 14α-Demethylase (CYP51)/Heat Shock Protein 90 (Hsp90) Dual Inhibitors for the Treatment of Invasive Candidiasis

The Center for Basic Research and Innovation of Medicine and Pharmacy (MOE), School of Pharmacy, Second Military Medical University (Naval Medical University), 325 Guohe Road, Shanghai 200433, China ...
Frontiers

Abnormal Ergosterol Biosynthesis Activates Transcriptional Responses to Antifungal Azoles

Fungal diseases in crops significantly contribute to yield loss and mycotoxin contaminations (Dean et al., 2012), while invasive fungal infections in immunodeficient patients are often the cause for ...
Φορολογία

Ρύθμιση οφειλόμενων ασφαλιστικών εισφορών (παρ.β του άρθρου 21 του Ν.4038/2012 (ΦΕΚ 14Α/2-2-2012)

ΘΕΜΑ: «Ρύθμιση οφειλόμενων ασφαλιστικών εισφορών (παρ.β του άρθρου 21 του Ν.4038/2012 (ΦΕΚ 14Α/2-2-2012)». Με τις διατάξεις της παρ. β του άρθρου 21 του Ν.